![Christian Behrenbruch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Behrenbruch
Fondateur chez
TELIX PHARMACEUTICALS LIMITED
Fortune : 246 M $ au 30/06/2026
Profil
Christian P.
Behrenbruch was the founder of ImaginAb, Inc. (2007) as Chief Executive Officer & Director and Telix Pharmaceuticals Ltd. (2015) as Group CEO, MD & Executive Director.
Dr. Behrenbruch is also the founder of Amplia Therapeutics Pty Ltd. Current jobs include Chairman at Monash Engineering Foundation, Managing Director at Irukandji Research Pty Ltd., and Director at Advanced Nuclear Medicine Ingredients SA since 2018.
Former jobs include Chief Executive Officer at Fibron Technologies, Inc. (2008-2011), Chief Executive Officer at Mirada Solutions Ltd. (2001-2002), Chairman at Cell Therapies Pty Ltd. (2012-2014), Non-Executive Director at Invert Graphite Ltd. (2017-2021), Director at Oncidium Foundation, Independent Director at Amplia Therapeutics Ltd. (2018-2020), Director at Siemens Molecular Imaging, Inc. (2005-2006), Director at Momentum Biosciences LLC (2007-2009), Director at Radius Health, Inc. (2009-2011), and President at CTI Molecular Imaging, Inc. (2003-2006).
Education includes a graduate degree from the University of Melbourne, a doctorate from the University of Oxford, an MBA from New York University, and an MBA from École des Hautes Études Commerciales de Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2026 | 21 396 941 ( 6,3% ) | 246 M $ | 30/06/2026 |
Postes actifs de Christian Behrenbruch
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Fondateur | 01/11/2015 |
Advanced Nuclear Medicine Ingredients SA
 Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Distributes pharmaceutical ingredients | Directeur/Membre du Conseil | 21/12/2018 |
Amplia Therapeutics Pty Ltd.
 Amplia Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fondateur | - |
Irukandji Research Pty Ltd. | Corporate Officer/Principal | - |
Monash Engineering Foundation | Président | - |
Anciens postes connus de Christian Behrenbruch
| Sociétés | Poste | Fin |
|---|---|---|
| INVERT GRAPHITE LIMITED | Directeur/Membre du Conseil | 28/05/2021 |
| AMPLIA THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 01/02/2020 |
ImaginAb, Inc.
 ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Fondateur | 01/02/2015 |
Cell Therapies Pty Ltd. | Président | 01/07/2014 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Christian Behrenbruch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
CTI Molecular Imaging, Inc.
 CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology Makes positron emission tomography scanners | Health Technology |
Invert Graphite Ltd.
 Invert Graphite Ltd. Construction MaterialsNon-Energy Minerals Engages in mining of lime and other minerals | Non-Energy Minerals |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirada Solutions Ltd.
 Mirada Solutions Ltd. Packaged SoftwareTechnology Services Developes software applications for medical imaging | Technology Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapies Pty Ltd. | |
Siemens Molecular Imaging, Inc. | |
Fibron Technologies, Inc.
 Fibron Technologies, Inc. Chemicals: SpecialtyProcess Industries Developes organic polymer materials | Process Industries |
ImaginAb, Inc.
ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Health Technology |
Momentum Biosciences LLC
 Momentum Biosciences LLC Investment ManagersFinance Operates as a venture capital company | Finance |
Amplia Therapeutics Ltd.
 Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
Monash Engineering Foundation | |
Oncidium Foundation | |
Irukandji Research Pty Ltd. | |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Distributes pharmaceutical ingredients | Distribution Services |
Amplia Therapeutics Pty Ltd.
Amplia Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Choisissez Zonebourse 
